de Craen A J, Di Giulio G, Lampe-Schoenmaeckers J E, Kessels A G, Kleijnen J
Department of Clinical Epidemiology and Biostatistics, University of Amsterdam, Netherlands.
BMJ. 1996 Aug 10;313(7053):321-5. doi: 10.1136/bmj.313.7053.321.
To assess whether adding codeine to paracetamol has an additive analgesic effect; to assess the safety of paracetamol-codeine combinations versus paracetamol alone.
Systematic literature review with meta-analysis, methodological quality of published trials being scored by means of 13 predefined criteria.
24 of 29 trials that met the inclusion criteria. Models studied in the trials were postsurgical pain (21), postpartum pain (one), osteoarthritic pain (one), and experimentally induced pain (one).
Dosages ranged from 400 to 1000 mg paracetamol and 10 to 60 mg codeine.
The sum pain intensity difference (efficacy analysis) and the proportion of patients reporting a side effect (safety analysis).
Most trials were considered of good to very good quality. Only the single dose studies could be combined for analysis of analgesic efficacy. Pooled efficacy results indicated that codeine added to paracetamol provided a 5% increase in analgesia on the sum pain intensity difference. This effect was comparable to the difference in analgesic effect between codeine and placebo. The cumulative incidence of side effects with each treatment was comparable in the single dose trials. In the multidose studies a significantly higher proportion of side effects occurred with paracetamol-codeine preparations.
The difference is analgesic effect between paracetamol-codeine combinations and paracetamol alone was small but statistically significant. In the multidose studies the proportion of patients reporting a side effect was significantly higher with paracetamol-codeine combinations. For occasional pain relief a paracetamol-codeine combination might be appropriate but repeated use increases the occurrence of side effects.
评估在对乙酰氨基酚中添加可待因是否具有附加镇痛效果;评估对乙酰氨基酚 - 可待因组合与单独使用对乙酰氨基酚的安全性。
系统文献综述及荟萃分析,采用13项预定义标准对已发表试验的方法学质量进行评分。
29项试验中有24项符合纳入标准。试验中研究的模型包括术后疼痛(21项)、产后疼痛(1项)、骨关节炎疼痛(1项)和实验性诱导疼痛(1项)。
对乙酰氨基酚剂量范围为400至1000毫克,可待因剂量范围为10至60毫克。
疼痛强度差值总和(疗效分析)以及报告有副作用的患者比例(安全性分析)。
大多数试验被认为质量良好至非常好。只有单剂量研究可合并用于镇痛疗效分析。汇总的疗效结果表明,在对乙酰氨基酚中添加可待因使疼痛强度差值总和的镇痛效果提高了5%。这一效果与可待因和安慰剂之间的镇痛效果差异相当。在单剂量试验中,每种治疗的副作用累积发生率相当。在多剂量研究中,对乙酰氨基酚 - 可待因制剂出现副作用的比例显著更高。
对乙酰氨基酚 - 可待因组合与单独使用对乙酰氨基酚之间的镇痛效果差异虽小但具有统计学意义。在多剂量研究中,对乙酰氨基酚 - 可待因组合报告有副作用的患者比例显著更高。对于偶尔缓解疼痛,对乙酰氨基酚 - 可待因组合可能合适,但重复使用会增加副作用的发生。